Koers Genomic Health, Inc.
Aandelen
US37244C1018
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Kevin Conroy
CEO | Chief Executive Officer | 58 | 08-11-19 |
Jeffrey Elliott
DFI | Director of Finance/CFO | 46 | 08-11-19 |
D. Coward
SEC | Corporate Secretary | 59 | 08-11-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+64,92% | 62,59 mld. | |
-1,85% | 41,18 mld. | |
+44,76% | 40,29 mld. | |
-8,93% | 27,9 mld. | |
+13,05% | 26,21 mld. | |
-21,96% | 19,09 mld. | |
+4,21% | 13,08 mld. | |
+25,74% | 12,26 mld. | |
+27,42% | 12,05 mld. |